LOS ANGELES, Nov. 1, 2017 /PRNewswire/ -- Pacific Toxicology Laboratories responds to the dramatic increase in opioid overdosedeaths by developing expanded testing to detect fentanyl and fentanyl analogues in clinical settings.
Fentanyl and fentanyl analogues have been linked to the overdose deaths of over 20,000 men, women and children in the
Except for the post-mortem analyses, there is little data on the use and abuse of fentanyl analogues because these substances have not heretofore been included in addiction treatment drug screening. Pacific Toxicology Laboratories now routinely screens and quantitates the presence of the following fentanyl analogues in urine samples: Butyryl Fentanyl, N-Phenyl –1– 4 - Piperidianamine, Furanyl Fentanyl, Ocfentanil, Acetyl Fentanyl, Alfentanil, Remifentanil, Sufentanil, Valeryl Fentanyl, Para-Fluorofentanyl, (+/-)CIS- 3- Methyl Fentanyl, Carfentanil, and Nor Carfentanil.
Established in 1984, Pacific Toxicology Laboratories is an independent SAMHSA (Substance Abuse Mental Health Services Administration) certified and CLIA licensed laboratory. Pacific Toxicology Laboratories offers comprehensive testing services for substance abuse and mental health treatment centers.
If you would be interested in learning more contact Donald Simpson, M.D. or Jeff Lanzolatta at 818-678-4459 or go to http://www.pactox.com and click on latest news.
View original content:http://www.prnewswire.com/news-releases/expanded-testing-to-detect-fentanyl-and-fentanyl-analogues-in-clinical-settings-300548043.html
SOURCE Pacific Toxicology Laboratories
Subscribe to our Free Newsletters!
Drug abuse is a negative social trend that pushes youth to drug addiction in the pretext of getting ...
Proper understanding of waste collection, segregation and management is required to reduce the ...
Leukoplakia refers to a painless, raised white patch in the mouth that does not go away on rubbing, ...View All